InvestSMART

Zelira Therapeutics Limited (ASX: ZLD) - Announcements

- Current share price for ZLD : $0.500

ASX company news and announcements for Zelira Therapeutics Limited (ZLD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Zelira Therapeutics Limited (ZLD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Zelira Therapeutics Limited (ZLD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Zelira Therapeutics Limited (ZLD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$6 2023 Annual General Meeting Presentation 15 Nov 2023 11:39AM $0.950 $0.500 fallen by 47.37%
$6 Notification of cessation of securities - ZLD 13 Nov 2023 2:32PM $1.050 $0.500 fallen by 52.38%
$6 Notification of cessation of securities - ZLD 3 Nov 2023 2:26PM $0.990 $0.500 fallen by 49.49%
$6 Appendix 4C Cash Flow Report 31 Oct 2023 10:15AM $0.910 $0.500 fallen by 45.05%
$6 September 2023 Quarterly Activities Report 31 Oct 2023 10:14AM $0.910 $0.500 fallen by 45.05%
$6 Letter to Shareholders 16 Oct 2023 5:32PM $0.950 $0.500 fallen by 47.37%
$6 Notice of Annual General Meeting/Proxy Form 16 Oct 2023 5:32PM $0.950 $0.500 fallen by 47.37%
$6 Appendix 4G and Corporate Governance Statement 29 Sep 2023 2:19PM $0.980 $0.500 fallen by 48.98%
$6 Annual Report to shareholders 29 Sep 2023 2:19PM $0.980 $0.500 fallen by 48.98%
$6 Change of registry address notification 15 Sep 2023 4:32PM $0.995 $0.500 fallen by 49.75%
$6 AGM Date and Closing Date for Director Nominations 15 Sep 2023 4:29PM $0.995 $0.500 fallen by 49.75%
$6 Change of Director's Interest Notice 11 Sep 2023 4:03PM $0.990 $0.500 fallen by 49.49%
$6 Notification of cessation of securities - ZLD 11 Sep 2023 4:00PM $0.990 $0.500 fallen by 49.49%
$6 Preliminary Final Report 31 Aug 2023 1:19PM $1.105 $0.500 fallen by 54.75%
$6 Zelira closes $3.25M funding as part of HOPE SPV fundraise 17 Aug 2023 8:21AM $1.490 $0.500 fallen by 66.44%
$6 Notification of cessation of securities - ZLD 14 Aug 2023 11:32AM $1.580 $0.500 fallen by 68.35%
$6 Appendix 4C Cash Flow Report 31 Jul 2023 4:13PM $1.630 $0.500 fallen by 69.33%
$6 June 2023 Quarterly Activities Report 31 Jul 2023 4:12PM $1.630 $0.500 fallen by 69.33%
$6 Amendment to ASX announcement - Zelira's diabetic nerve pai 8 Jun 2023 9:47AM $2.160 $0.500 fallen by 76.85%
$6 Initial Director's Interest Notice 1 Jun 2023 3:29PM $2.100 $0.500 fallen by 76.19%
$6 Final Director's Interest Notice 1 Jun 2023 3:27PM $2.100 $0.500 fallen by 76.19%
$6 Proposed issue of securities - ZLD 31 May 2023 4:22PM $3.050 $0.500 fallen by 83.61%
$6 Zelira Non-Executive Director Appointed 31 May 2023 4:14PM $3.050 $0.500 fallen by 83.61%
$6 Top Line Results Investor Presentation 31 May 2023 11:46AM $2.900 $0.500 fallen by 82.76%
$6 Investor Webinar - Top line trial results 31 May 2023 10:41AM $1.200 $0.500 fallen by 58.33%

76 - 100 of 541 results

Page 4 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.